2-((4-(4-Bromophenyl)-5-(pyridin-3-yl)-4H-1,2,4-triazol-3-yl)thio)-N-(3-fluorophenyl)acetamide

Catalog No. :
ACIDSS295
CAS No. :
477331-26-3
Molecular Formula :
C21H15BrFN5OS
Molecular Weight :
484.35

IUPAC Name:2-((4-(4-bromophenyl)-5-(pyridin-3-yl)-4H-1,2,4-triazol-3-yl)thio)-N-(3-fluorophenyl)acetamide

2-((4-(4-Bromophenyl)-5-(pyridin-3-yl)-4H-1,2,4-triazol-3-yl)thio)-N-(3-fluorophenyl)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-((4-(4-Bromophenyl)-5-(pyridin-3-yl)-4H-1,2,4-triazol-3-yl)thio)-N-(3-fluorophenyl)acetamide
IUPAC Name2-((4-(4-bromophenyl)-5-(pyridin-3-yl)-4H-1,2,4-triazol-3-yl)thio)-N-(3-fluorophenyl)acetamide
Molecular FormulaC21H15BrFN5OS
Molecular Weight484.35
SMILESO=C(NC1=CC=CC(F)=C1)CSC2=NN=C(C3=CC=CN=C3)N2C4=CC=C(Br)C=C4
InChI KeyYWXJIPQSYIWGPI-UHFFFAOYSA-N
SynonymSALOR-INT L244759-1EA;2-((4-(4-BR-PH)-5-(3-PYRIDINYL)-4H-1,2,4-TRIAZOL-3-YL)THIO)-N-(3-F-PH)ACETAMIDE;2-{[4-(4-bromophenyl)-5-(pyridin-3-yl)-4H-1,2,4-triazol-3-yl]sulfanyl}-N-(3-fluorophenyl)acetamide;Acetamide, 2-[[4-(4-bromophenyl)-5-(3-pyridinyl)-4H-1,2,4-triazol-3-yl]thio]-N-(3-fluorophenyl)-
CAS No.477331-26-3

Synthetic Route by SureRoute

1. ACIDSS295 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFBNJ219 route compound structure diagram
    ACFBNJ2191993-09-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIDSS295 route product structure diagram
    ACIDSS295477331-26-3
Inquiry

2. ACIDSS295 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIDSS295 route product structure diagram
    ACIDSS295477331-26-3
Inquiry

Comments (0)